Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harvard Bioscience (HBIO)
NASDAQ:HBIO
Holding HBIO?
Track your performance easily
HBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.30 - $5.56
Previous Close$2.4
Volume72.78K
Average Volume (3M)108.30K
Market Cap
$104.67M
Enterprise Value$141.01M
Total Cash (Recent Filing)$4.05M
Total Debt (Recent Filing)$40.39M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 07, 2024EPS Estimate
$0.02Last Dividend Ex-Date
Nov 04, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding43,610,883
10 Day Avg. Volume98,998
30 Day Avg. Volume108,297
Standard Deviation0.15
R-Squared0.21
Alpha-0.00769
Financial Highlights & Ratios
Price to Book (P/B)1.56
Price to Sales (P/S)1.04
Price to Cash Flow (P/CF)-30.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.39
Enterprise Value/Gross Profit2.13
Enterprise Value/Ebitda-62.67
Forecast
1Y Price Target
$6.25Price Target Upside163.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Harvard Bioscience News
Ownership Overview
10.81% Insiders
19.55% Mutual Funds
1.31% Other Institutional Investors
58.91% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HBIO FAQ
What was Harvard Bioscience’s price range in the past 12 months?
Harvard Bioscience lowest stock price was $2.30 and its highest was $5.56 in the past 12 months.
What is Harvard Bioscience’s market cap?
Currently, no data Available
When is Harvard Bioscience’s upcoming earnings report date?
Harvard Bioscience’s upcoming earnings report date is Nov 07, 2024 which is in 3 days.
How were Harvard Bioscience’s earnings last quarter?
Harvard Bioscience released its earnings results on Aug 08, 2024. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.05 by -$0.05.
Is Harvard Bioscience overvalued?
According to Wall Street analysts Harvard Bioscience’s price is currently Undervalued.
Does Harvard Bioscience pay dividends?
Harvard Bioscience pays a Notavailable dividend of $1.34 which represents an annual dividend yield of N/A. See more information on Harvard Bioscience dividends here
What is Harvard Bioscience’s EPS estimate?
Harvard Bioscience’s EPS estimate is $0.02.
How many shares outstanding does Harvard Bioscience have?
Harvard Bioscience has 43,610,880 shares outstanding.
What happened to Harvard Bioscience’s price movement after its last earnings report?
Harvard Bioscience reported an EPS of $0 in its last earnings report, missing expectations of $0.05. Following the earnings report the stock price went up 11.828%.
Which hedge fund is a major shareholder of Harvard Bioscience?
Among the largest hedge funds holding Harvard Bioscience’s share is Harvey Partners LLC. It holds Harvard Bioscience’s shares valued at 7M.
---
Harvard Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.25 (163.71% Upside)
$6.25 (163.71% Upside)
Hedge Fund Trend
Increased
By 107.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.30%
12-Months-Change
Fundamentals
Return on Equity
-14.97%
Trailing 12-Months
Asset Growth
-9.79%
Trailing 12-Months
Company Description
Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
---
HBIO Company Deck
---
HBIO Earnings Call
Q2 2024
0:00 / 0:00
---
HBIO Stock 12 Month Forecast
Average Price Target
$6.25
▲(163.71% Upside)
Technical Analysis
Best Analysts Covering HBIO
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
+8.24%
reiterated a buy rating 3 months ago
Copying Bruce Jackson's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +8.24% per trade.
---